Katie Lynne Strong is a patent agent in our Intellectual Property and Technology practice and has extensive experience in all aspects of global patent protection, including US and international patent prosecution, patentability and freedom to operate analysis, and due diligence. Katie’s scientific acumen; notably her expertise in organic chemistry, medicinal chemistry, nucleoside chemistry, drug design, pharmacology, electrophysiology, anti-viral drugs, and ocular and polymeric formulation, is highly valued by a broad spectrum of clients, particularly those in the biotechnology, chemical and pharmaceutical industries.
    Award Mouse thought multimedia interface book medal screen monitor

    Education

    • Emory University, Ph.D., Organic Chemistry, 2015
    • University of Mary Washington, Chemistry, Cum Laude, 2010

    Admissions

    • U.S. Patent and Trademark Office, 2017

    • Strong K.L.; Epplin M.P.; Ogden K.K.; Burger P.B.; Kaiser T.M.; Wilding T.J.; Kusumoto H.; Camp C.R.; Shaulsky G; Bhattacharya S; Perszyk R.E.; Menaldino D.S.; McDaniel M.J.; Zhang J.; Le P.; Banke T.G.; Hansen K.B.; Huettner J.E.; Liotta D.C.; Traynelis S.F.; Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate Receptors. ACS Chem Neurosci. 2021, 12, 79-98.
    • Strong, K.L. Epplin, M.P.; Bacsa, J.; Butch, Cj.; Burger, P.B.; Menaldino, D.S.; Traynelis, S. F.; Liotta, D.C. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors. Journal of Medicinal Chemistry. 2017, 60, 5556-5585.
    • Strong, K.L.; Epplin, M.P.; Jing, Y.; Traynelis, S.F.; Liotta, D.C. Mechanism of action of a GluN2C- and GluN2D-selective NMDA receptor positive allosteric modulator. In Allosterism in Drug Discovery, Dotter, D., Ed.; Royal Society of Chemistry; Cambridge, 2016; pp 281-309.
    • Strong K.L.; Jing Y.; Prosser A.R.; Traynelis S.F.; Liotta D.C. NMDA receptor modulators: an updated patent review (2013-2014). Expert Opin Ther Pat. 2014, 24, 1349-66.
    • Perszyk, R.E.; DiRaddo, .1.0.; Strong, K.L.; Low, C.; Ogden, K.K.; Khatri, A.; Vargish, G.A.; Pelkey, K.A.; Tricoire, L.; Liotta, D.C.; Smith, Y.; McBain, C.J.; Traynelis, S.F. GluN2D-containing N-methyl-D-aspartate receptors mediate synaptic transmission in Hippocampal Interneurons and Regulate Interneuron Activity. Mol Pharmacol. 2016, 90, 689-702. 
    • Santangelo, R.M.; Ogden, K.K.; Strong, K.L.; Khatri, A.; Chepiga, K.M.; Jensen, H.S.; Traynelis, S.F.; Liotta, D.C. Synthesis and Structure Activity Relationship of Tetrahydroisoquinoline-based Potentiators of GIuN2C and GIuN2D Containing N-Methyl-D-Aspartate Receptors. Med. Chem. 2013, 56, 5351-5381.
    • Santangelo, R.M.; Acker, T.M.; Zimmerman, SS; Katzman, B.M.; Strong, K.L.; Traynelis, S.F.; Liotta, D.C. Novel NMDA receptor modulators: an update. Expert Opinion on Therapeutic Patents. 2012, 22, 1337-1352.

    Award Mouse thought multimedia interface book medal screen monitor